Paper Details

  1. Home
  2. Paper Details

Effects on sexual function in Japanese patients with benign prostatic hyperplasia upon switching from combination therapy with α1 blocker and dutasteride to combination therapy with tadalafil and dutasteride.

Author: MiuraKunihisa, MizushimaAkio, WatanabeDaisuke, YamashitaAkemi

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Switching from combination therapy with an α1 blocker (AB) and dutasteride (DUT) to combination therapy with tadalafil (TAD) and DUT significantly improved erectile function in Japanese patients with benign prostatic hyperplasia (BPH).
Paper Details　
Original Abstract of the Article :
This study investigated what sort of effects would occur in terms of sexual function in Japanese patients with benign prostatic hyperplasia (BPH), upon switching from combination therapy with an α1 blocker (AB) and dutasteride (DUT) to combination therapy with tadalafil (TAD) and DUT. The basel...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/13685538.2018.1538336

データ提供：米国国立医学図書館（NLM）

Effects on Sexual Function in Patients with Benign Prostatic Hyperplasia

This study investigates the effects of switching treatment regimens for benign prostatic hyperplasia (BPH) on sexual function. BPH is a condition characterized by an enlarged prostate gland, which can lead to urinary problems. This research explores the impact of different medication combinations on sexual function, which is like navigating a desert where different types of water sources can have varying effects on thirst and hydration.

Switching Medication Regimens for BPH

The researchers found that switching from a combination therapy of an α1 blocker (AB) and dutasteride (DUT) to a combination of tadalafil (TAD) and DUT significantly improved erectile function in Japanese patients with BPH. This is like finding a new oasis in the desert that provides a more refreshing and revitalizing source of water. The study also found that the new medication combination did not significantly worsen urinary symptoms.

Health Benefits and Lifestyle Implications

This research provides valuable information for healthcare professionals managing BPH. It's like mapping out a new path through a desert, offering a more efficient and comfortable route to alleviate symptoms. This study suggests that switching to a TAD/DUT combination therapy can provide significant benefits for both urinary and sexual function in patients with BPH.

Dr. Camel's Conclusion

This study highlights the importance of considering the impact of medication regimens on sexual function. It's like understanding the different ways that water can be used in a desert, from providing hydration to supporting agriculture. This research provides evidence for the potential benefits of switching to a TAD/DUT combination therapy for patients with BPH, offering hope for a better quality of life.

Date :
  1. Date Completed 2021-10-25
  2. Date Revised 2021-10-25
Further Info :

Pubmed ID

30457437

DOI: Digital Object Identifier

10.1080/13685538.2018.1538336

Related Literature

Article Analysis
・Effects of dutasteride
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.